| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AGEING/AFJ087 |
| P698 | PubMed publication ID | 16638765 |
| P50 | author | Kallol Ray Chaudhuri | Q45913613 |
| P2093 | author name string | S Pal | |
| V Dhawan | |||
| D G Healy | |||
| P2860 | cites work | Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 |
| Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 | Q28244224 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| Waking up to sleep episodes in Parkinson's disease | Q33884385 | ||
| Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases | Q33887811 | ||
| An essay on the shaking palsy. 1817. | Q33958859 | ||
| The sleep switch: hypothalamic control of sleep and wakefulness | Q34446039 | ||
| Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole | Q34503884 | ||
| The effects of pramipexole in REM sleep behavior disorder | Q34543495 | ||
| Nocturnal symptom complex in PD and its management | Q35540910 | ||
| The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease | Q35560075 | ||
| Idiopathic REM sleep behavior disorder: toward a better nosologic definition | Q36064486 | ||
| CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. | Q40670797 | ||
| Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease | Q40846023 | ||
| Daytime sleepiness and other sleep disorders in Parkinson's disease | Q43775099 | ||
| Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. | Q43882541 | ||
| Excessive daytime sleepiness in de novo and treated Parkinson's disease | Q44165259 | ||
| Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease | Q44351576 | ||
| Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease | Q44653423 | ||
| Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study | Q44820225 | ||
| Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. | Q45153446 | ||
| Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep | Q45185387 | ||
| Melatonin for sleep disturbances in Parkinson's disease | Q46637940 | ||
| Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients | Q47766482 | ||
| Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus | Q48601953 | ||
| Assessment of sleep and sleepiness in Parkinson disease | Q48603917 | ||
| Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS | Q48614297 | ||
| Parkinson's disease and sleepiness: an integral part of PD. | Q48664975 | ||
| Fatigue in patients with Parkinson's disease | Q48769057 | ||
| Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease | Q48878240 | ||
| Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder | Q49153394 | ||
| Hypocretin (orexin) deficiency in human narcolepsy. | Q55033530 | ||
| P433 | issue | 3 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 220-228 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Age and Ageing | Q4691852 |
| P1476 | title | Sleep-related problems of Parkinson's disease | |
| P478 | volume | 35 |
| Q26744733 | A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures |
| Q33531451 | A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers. |
| Q36787926 | Balancing short-term symptom control and long-term functional outcomes in patients with Parkinson's disease. |
| Q31028156 | Case control polysomnographic studies of sleep disorders in Parkinson's disease |
| Q34241641 | Cellular stress/the unfolded protein response: relevance to sleep and sleep disorders |
| Q92649112 | Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease |
| Q47886647 | Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson's disease |
| Q28384426 | Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model |
| Q58760662 | Clinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease |
| Q40324460 | Clinical characteristics of sleep disorders in patients with Parkinson's disease |
| Q64895709 | Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version |
| Q35062700 | Daytime napping, nighttime sleeping, and Parkinson disease |
| Q43728140 | Disturbed sleep in Parkinson's disease: anatomical and pathological correlates |
| Q36935143 | Dopamine and Consolidation of Episodic Memory: Timing is Everything. |
| Q38153751 | Effects of rotigotine on Parkinson's disease-related sleep disturbances |
| Q36443721 | Evaluation and management of the non-motor features of Parkinson's disease |
| Q37842431 | Excessive daytime sleepiness in patients with Parkinson's disease |
| Q90356139 | Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson's Disease: A Randomized Controlled Trial |
| Q47431800 | Insomnia, Sleep Quality, and Quality of Life in Mild to Moderate Parkinson's Disease |
| Q39782647 | Night-time sleep in Parkinson's disease - the potential use of Parkinson's KinetiGraph: a prospective comparative study |
| Q37449905 | Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment |
| Q48275749 | Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. |
| Q33812515 | Observations on sleep-disordered breathing in idiopathic Parkinson's disease |
| Q34901847 | Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients |
| Q33731267 | Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis? |
| Q92786736 | Prevalence of sleep disorders in Parkinson's disease patients in two neurology referral hospitals in Ethiopia |
| Q34574771 | Psychiatric aspects of Parkinson's disease |
| Q34374820 | Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance |
| Q38004940 | Roles of endoplasmic reticulum and energetic stress in disturbed sleep |
| Q41620763 | Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? |
| Q99238165 | Sleep Disturbances and Sleep Disordered Breathing Impair Cognitive Performance in Parkinson's Disease |
| Q35028804 | Sleep Duration and "on" Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release |
| Q52142287 | Sleep Dysfunction in Parkinson's Disease. |
| Q34203614 | Sleep alterations in an environmental neurotoxin-induced model of parkinsonism |
| Q36725295 | Sleep and non-motor symptoms in Parkinson's disease |
| Q38687864 | Sleep disorders and an increased risk of Parkinson's disease in individuals with non-apnea sleep disorders: a population-based cohort study |
| Q81521040 | Sleep disorders in Parkinson's disease |
| Q48104086 | Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein |
| Q48329995 | Sleep dysfunction and role of dysautonomia in Parkinson's disease |
| Q48350404 | Sleep patterns in Parkinson's disease patients with visual hallucinations |
| Q47656700 | Sleep quality is associated with the severity of clinical symptoms in Parkinson's disease. |
| Q64767243 | The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version |
| Q37796036 | The challenge of non-motor symptoms in Parkinson's disease |
| Q37519557 | The endoplasmic reticulum stress response and aging |
| Q37982309 | The management of sleep and circadian disturbance in patients with dementia |
| Q39311516 | The many facets of motor learning and their relevance for Parkinson's disease |
| Q35276597 | Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection |
| Q47198603 | Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep |
| Q37874195 | When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease |
Search more.